Enovis CORP (Colfax Corporation) 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Colfax Corporation (the registrant) on February 21, 2020. The filing serves to report financial results for the fourth quarter ended December 31, 2019. The company is incorporated in Delaware and trades on the New York Stock Exchange under the symbol CFX.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It only confirms the issuance of a press release regarding Q4 2019 results.
Guidance, Outlook, and Management Commentary
Management scheduled a conference call for 8:00 a.m. Eastern on February 21, 2020, to discuss the financial results. The filing does not contain specific guidance, outlook statements, risk factors, or details on contingencies and unusual items within the text provided.
Investor Verification Checklist
- Review Exhibit 99.1 (the attached press release) for specific Q4 2019 revenue, earnings, and cash flow figures.
- Verify the company's current legal name, as the filing lists "Colfax Corporation" while the request metadata references "Enovis CORP."
- Check the transcript or recording of the February 21, 2020 conference call for management commentary and forward-looking guidance.
- Confirm the status of the 5.75% Tangible Equity Units (CFXA) listed as registered securities.